Vascular Endothelin ET(B) Receptor-Mediated Contraction Requires Phosphorylation of ERK1/2 Proteins.

Guogang Luo,Roya Jamali,Yong-Xiao Cao,Lars Edvinsson,Cang-Bao Xu
DOI: https://doi.org/10.1016/j.ejphar.2006.03.057
IF: 5.195
2006-01-01
European Journal of Pharmacology
Abstract:In cardiovascular diseases, endothelin type B (ET(B)) receptors in arterial smooth muscle cells are upregulated. The present study revealed that organ culture of rat mesenteric artery segments enhanced endothelin ET(B) receptor-mediated contraction paralleled with increase in the receptor mRNA and protein expressions. The endothelin ET(B) receptor-mediated contraction was associated with increase in phosphorylation of extracellular regulation kinase 1 and 2 (ERK1/2) proteins and elevated levels of intracellular calcium. The elevation curve of intracellular calcium consisted of two phases: one rapid and one sustained. Inhibition of ERK1/2 phosphorylation by SB386023 or blockage of calcium channels by nifedipine significantly reduced the endothelin ET(B) receptor-mediated contraction (P<0.05) and decreased the sustained phase of intracellular calcium level, but not the rapid phase. Thus, phosphorylation of ERK1/2 proteins and elevation of intracellular calcium level are required for endothelin ET(B) receptor-mediated contraction in rat mesenteric artery.
What problem does this paper attempt to address?